Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers

被引:43
作者
Bruhwyler, Jacques [3 ]
Carreer, Fabienne [3 ]
Demanet, Etienne [2 ]
Jacobs, Heidi [1 ]
机构
[1] Cosucra Grp Warcoing Sa, B-7740 Warcoing, Belgium
[2] ResearchLink Sprl, Thuin, Belgium
[3] Squarepoint Pointcarre Sprl, Ecaussinnes, Belgium
关键词
Inulin; fructan; tolerance; gastro-intestinal; healthy volunteers; HUMAN COLONIC MICROBIOTA; FECAL BIFIDOBACTERIA; DIETARY MODULATION; CHICORY INULIN; OLIGOFRUCTOSE; OLIGOSACCHARIDES; GLUCOSE; FIBER;
D O I
10.1080/09637480701625697
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Background Similar to other indigestible carbohydrates or dietary fibres, a consumption of too large quantities of inulin-type fructans may cause some digestive problems. Aim To compare the digestive tolerance of inulin-type fructans, administered during 2 weeks, at different doses. Methods Eighty-four healthy volunteers (aged 18-45 years, mean body mass index 25.1 kg/m2 and mean total fibre consumption 12 g) were included in a double-blind, placebo-controlled, randomized, cross-over study comparing Fibrulose F97 (5 and 20 g/day), Fibruline Instant (5, 10 and 20 g/day) and Fibruline XL (10 g/day) (degrees of polymerization respectively equal to 2-20, 2-60 with an average of 10, and 2-60 with an average 20) to placebo. The study was decomposed into five 2-week periods: placebo run-in, treatment 1, placebo washout, treatment 2, placebo run-out. The following symptoms were assessed using visual analogue scales: flatulence, rumbling, bloating, abdominal pain, abdominal cramps, nausea, stool frequency and stool consistency. The primary variable was the mean difference between treatment and placebo in terms of tolerance (sum of the eight visual analogue scales). Results The three products tended to increase digestive symptoms whatever the dose but the change was mild (maximum, +19 mm on the 800-mm scale) and significant (P0.001) for Fibruline Instant at 20 g/day only. At 20 g/day, a statistically significant difference between Fibruline Instant and Fibrulose F97 was demonstrated (P=0.011). There was a dose-effect relationship both for Fibrulose F97 (P0.05) and Fibruline Instant (P=0.042). All the other tendencies were non-significant. Conclusions The three different inulin-type fructans were very well tolerated.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 50 条
  • [1] Acute fiber supplementation with inulin-type fructans curbs appetite sensations: a randomized, double-blind, placebo-controlled study
    Salmean, Younis A.
    FOOD & NUTRITION RESEARCH, 2017, 61
  • [2] Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo-controlled, randomized, double-blind, cross-over study
    Laine, Fabrice
    Laviolle, Bruno
    Bardou-Jacquet, Edouard
    Fatih, Nadia
    Jezequel, Caroline
    Collet, Nicolas
    Ropert, Martine
    Morcet, Jeff
    Hamon, Catherine
    Reymann, Jean-Michel
    Loreal, Olivier
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (05) : 567 - 573
  • [3] Prebiotic effect of oligofructose after 2 weeks supplementation with a low dose: A randomized, double-blind, placebo-controlled, cross-over study
    Van Harsselaar, Jessica
    Moedinger, Yvonne
    Dharsono, Tanita
    Menzel, Daniel
    Theis, Stephan
    Schoen, Christiane
    JOURNAL OF FUNCTIONAL FOODS, 2024, 119
  • [4] A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans
    Kolida, S.
    Meyer, D.
    Gibson, G. R.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2007, 61 (10) : 1189 - 1195
  • [5] Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study
    Healey, Genelle
    Murphy, Rinki
    Butts, Christine
    Brough, Louise
    Whelan, Kevin
    Coad, Jane
    BRITISH JOURNAL OF NUTRITION, 2018, 119 (02) : 176 - 189
  • [6] A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans
    S Kolida
    D Meyer
    G R Gibson
    European Journal of Clinical Nutrition, 2007, 61 : 1189 - 1195
  • [7] Effects of inulin-type fructans with different degrees of polymerization on inflammation, oxidative stress and endothelial dysfunction in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
    Ziaei, Rahele
    Shahshahan, Zahra
    Ghasemi-Tehrani, Hatav
    Heidari, Zahra
    Ghiasvand, Reza
    CLINICAL ENDOCRINOLOGY, 2022, 97 (03) : 319 - 330
  • [8] Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
    Zhu, Dalong
    Gan, Shenglian
    Liu, Yu
    Ma, Jianhua
    Dong, Xiaolin
    Song, Weihong
    Zeng, Jiao'e
    Wang, Guixia
    Zhao, Wenjuan
    Zhang, Qiu
    Li, Yukun
    Fang, Hui
    Lv, Xiaofeng
    Shi, Yongquan
    Tian, Haoming
    Ji, Linong
    Gao, Xin
    Zhang, Lihui
    Bao, Yuqian
    Lei, Minxiang
    Li, Ling
    Zeng, Longyi
    Li, Xiaoying
    Hou, Xinghua
    Zhao, Yu
    Hu, Tianxin
    Ge, Xiaoyun
    Zhao, Guiyu
    Li, Yongguo
    Zhang, Yi
    Chen, Li
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (08) : 627 - 636
  • [9] Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study
    Cloetens, Lieselotte
    Broekaert, Willem F.
    Delaedt, Yasmine
    Ollevier, Frans
    Courtin, Christophe M.
    Delcour, Jan A.
    Rutgeerts, Paul
    Verbeke, Kristin
    BRITISH JOURNAL OF NUTRITION, 2010, 103 (05) : 703 - 713
  • [10] Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study
    Christoph Beglinger
    Ke Hu
    Ying Wang
    Emmanuel Bouillaud
    Christelle Darstein
    Yanfeng Wang
    Pharis Mohideen
    Endocrine, 2012, 42 : 366 - 374